Title Drug Industry Antitrust Act : hearings before the Antitrust Subcommittee (Subcommittee No. 5) of the Committee on the Judiciary, House of Representatives, Eighty-seventh Congress, second session, on H.R. 6245, a bill to amend and supplement the antitrust laws with respect to the manufacture and distribution of drugs, and for other purposes, May 17, 18, 23, and 24, 1962

Published Washington : U.S. Government Printing Office, 1962

Click on the following:
Hein Online books

Copies

Description 1 online resource (vii, 908 pages) : illustrations Summary Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs Considers (87) S. 1552, (87) H.R. 6245 Notes "Serial No. 32." Emanuel Celler, subcommittee chairman Online resource (HeinOnline, viewed October 10, 2017) Subject United States. Food and Drug Administration. SUBJECT United States. Food and Drug Administration fast Subject Pharmaceutical policy -- United States Drugs -- Law and legislation -- United States Pharmaceutical industry -- Standards -- United States Antitrust law -- United States Pharmaceutical policy Antitrust law Drugs -- Law and legislation Pharmaceutical industry -- Standards United States Genre/Form Legislative hearings Legislative hearings. Audiences législatives. Form Electronic book

OTHER TI LexisNexis U.S. Congressional Hearings Digital Collection. http://id.loc.gov/authorities/names/no2011070358

  Permalink